NCT05195723View on ClinicalTrials.gov

Study to Assess the Safety and Pharmacokinetics of WP1122 in Healthy Volunteers

PHASE1CompletedINTERVENTIONAL
Enrollment

48

Participants

Timeline

Start Date

May 11, 2022

Primary Completion Date

October 24, 2022

Study Completion Date

October 24, 2022

Conditions
Healthy Volunteer
Interventions
DRUG

WP1122

Oral solution

DRUG

Placebo

Oral solution

Trial Locations (1)

Unknown

Medicines Evaluation Unit, Manchester

Sponsors
All Listed Sponsors
lead

Moleculin Biotech, Inc.

INDUSTRY

NCT05195723 - Study to Assess the Safety and Pharmacokinetics of WP1122 in Healthy Volunteers | Biotech Hunter | Biotech Hunter